SLC16A1 and triple-negative breast carcinoma: In triple negative breast cancer, miR-342-3p was found to directly reduce SLC16A1; as miR-342-3p was downregulated due to a lack of estrogen receptor, SLC16A1 levels were shown to be increased (Romero-Cordoba et al., 2018).